Analyst Insights

UBS Raises Esterline Technologies Price Target To $130

UBS analyst David E. Strauss reiterates a ‘Buy’ rating on Esterline Technologies Corp.

Maxim Reiterates Buy Rating And Raises Achillion Price Target To $22

In a research note issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating and boosted his price target on Achillion Pharmaceuticals (ACHN) to …

H.C. Wainwright Reiterates Buy On United Therapeutics

In a research note issued this morning, H.C.

Vertex Shares Will Outperform The Biotech Sector, Says H.C. Wainwright

In a research note released this morning, H.C.

H.C. Wainwright Initiates Coverage On EDAP At Buy, Announces $6 PT

In a research note issued this morning, H.C.

Roth Capital Initiates Research Coverage On Fusion IO Inc. With A Buy Rating

Roth Capital initiated coverage on Fusion IO Inc. (FIO) with a Buy rating and $12.

Intel Corporation Upgraded to Buy From Neutral At Roth Capital

Analyst Krishna Shankar of Roth Capital upgraded Intel Corporation (INTC) from Neutral to Buy, and boosted his price target on INTC from $28.00 to $35.

Roth Capital Maintains Buy Rating On Uranium Resources

Roth Capital reiterated coverage yesterday on Uranium Resources Inc. (URRE) with a Buy rating and $4.

UPDATE: Roth Capital Resumes Coverage On Conatus Pharmaceuticals

In a report published today, Roth Capital analyst Ed Arce resumed coverage on Conatus Pharmaceuticals Inc. (CNAT) with a Buy rating and $19.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts